World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

Chapter 9: Complement Activation

    https://doi.org/10.1142/9789813140455_0009Cited by:1 (Source: Crossref)
    Abstract:

    The complement system is the most important biochemical cascade in the blood for the recognition, opsonization, and elimination of foreign materials. To date, the leading causes of death in the United States include cancer, cardiovascular and neurodegenerative diseases, and diabetes. New treatments are urgently needed to treat these devastating diseases and nanotechnology potentially provides new avenues to fight such illnesses. These avenues include the development of novel nanocarriers that deliver drugs in a specific and controlled manner, while minimizing secondary effects. The success of bioengineering effective nanocarriers for drug delivery purposes requires a deep understanding of the interaction between the complement system and the nanocarriers. This review focuses on reporting the current state of complement activation by different nanomaterials. Here, we assess various important parameters that influence the activation of the complement system, which include the physicochemical characteristics of both nanocarriers and complement proteins. We next evaluate the most recent engineering approaches to prevent or reduce complement activation. Finally, we discuss different in vitro and in vivo procedures to assess complement activation.